1. Home
  2. ITP vs GRI Comparison

ITP vs GRI Comparison

Compare ITP & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IT Tech Packaging Inc.

ITP

IT Tech Packaging Inc.

HOLD

Current Price

$0.18

Market Cap

3.1M

ML Signal

HOLD

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$1.52

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITP
GRI
Founded
1996
2018
Country
China
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
3.6M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
ITP
GRI
Price
$0.18
$1.52
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$160.00
AVG Volume (30 Days)
273.2K
25.8K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
1.01
N/A
EPS
N/A
N/A
Revenue
$75,837,943.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.18
52 Week High
$0.39
$6.70

Technical Indicators

Market Signals
Indicator
ITP
GRI
Relative Strength Index (RSI) 49.58 46.51
Support Level $0.17 $0.20
Resistance Level $0.20 $2.35
Average True Range (ATR) 0.01 0.09
MACD 0.00 0.03
Stochastic Oscillator 47.06 73.08

Price Performance

Historical Comparison
ITP
GRI

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: